The deadliest Ebola outbreak in history began in West Africa in late 2013 and has killed more than 10,000 people, mainly in Liberia, Sierra Leone and Guinea. Thousands of healthcare workers in areas of Sierra Leone who are grappling with Ebola will now begin receiving an experimental vaccine, rVSV-ZEBOV, against the often deadly virus. The vaccine candidate has been developed by the Public Health Agency of Canada and licensed to NewLink Genetics and Merck pharmaceuticals. The ...
Read More
No comments:
Post a Comment